Detalhe da pesquisa
1.
Circulating tumor DNA monitoring for early recurrence detection in epithelial ovarian cancer.
Gynecol Oncol
; 167(2): 334-341, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36117009
2.
Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Cancer
; 127(8): 1275-1285, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33320347
3.
Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk.
Genet Med
; 20(2): 234-239, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28749474
4.
A clinical trial of lovastatin for modification of biomarkers associated with breast cancer risk.
Breast Cancer Res Treat
; 142(2): 389-98, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24166281
5.
Personalised Risk Prediction in Hereditary Breast and Ovarian Cancer: A Protocol for a Multi-Centre Randomised Controlled Trial.
Cancers (Basel)
; 14(11)2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681696
6.
Single-cell analyses define a continuum of cell state and composition changes in the malignant transformation of polyps to colorectal cancer.
Nat Genet
; 54(7): 985-995, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726067
7.
The Gastric Cancer Registry: A Genomic Translational Resource for Multidisciplinary Research in Gastric Cancer.
Cancer Epidemiol Biomarkers Prev
; 31(9): 1693-1700, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35771165
8.
Multicenter Prospective Cohort Study of the Diagnostic Yield and Patient Experience of Multiplex Gene Panel Testing For Hereditary Cancer Risk.
JCO Precis Oncol
; 32019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322651
9.
Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers.
Fam Cancer
; 7(2): 179-86, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18026853
10.
Therapeutic Implications of Oncogenic Missense HER2 (ERBB2) Mutations in Gastric Adenocarcinoma.
JCO Precis Oncol
; 7: e2200093, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36787506
11.
Pathogenic Variants in Less Familiar Cancer Susceptibility Genes: What Happens After Genetic Testing?
JCO Precis Oncol
; 2: 1-10, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135157
12.
Patient communication of cancer genetic test results in a diverse population.
Transl Behav Med
; 8(1): 85-94, 2018 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29385580
13.
Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk.
Cancer Epidemiol Biomarkers Prev
; 14(5): 1082-9, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15894656
14.
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
JAMA Oncol
; 1(7): 943-51, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26270727
15.
A Systematic Comparison of Traditional and Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Genes in More Than 1000 Patients.
J Mol Diagn
; 17(5): 533-44, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26207792
16.
Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
J Clin Oncol
; 32(19): 2001-9, 2014 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24733792
17.
Magnetic resonance galactography: a feasibility study in women with prior atypical breast duct cytology.
Breast J
; 14(2): 211-4, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18248552
18.
Feasibility evaluation of an online tool to guide decisions for BRCA1/2 mutation carriers.
Fam Cancer
; 12(1): 65-73, 2013 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-23086584
19.
Tumor Molecular Profiling Aids in Determining Tissue of Origin and Therapy for Metastatic Adenocarcinoma in a Patient With Multiple Primary Malignancies.
JCO Precis Oncol
; 2: 1-4, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135146
20.
Online tool to guide decisions for BRCA1/2 mutation carriers.
J Clin Oncol
; 30(5): 497-506, 2012 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22231042